Abstract
Objective: Self-microemulsifying drug delivery system (SMEDDS) of aceclofenac was developed to alleviate poor solubility and bioavailability issues.
Methods: The selection of components (oil, surfactant and co-surfactant) was based on saturated solubility studies and self emulsification ability. Pseudoternary phase diagrams were constructed to identify the self-emulsifying region. Isopropyl Myristate (IPM) was selected as oil phase; Cremophore as surfactant and Transcutol as co-surfactant (S/CoS mix) (in ratio of 1:1) respectively as optimized components for the SMEDDS formulation. The formulated liquid SMEDDS was evaluated for its self-emulsification time, phase separation, viscosity, cloud point and droplet size analysis. The liquid SMEDDS were converted to Solid SMEDDS by adsorption on solid carrier (Neusilin US2). Solid SMEDDS were further characterized for SEM, XRD, FTIR studies and evaluated for drug content, micrometric properties. Further Solid SMEDDS were compressed into tablet dosage form. Results: In vitro drug release of liquid and Solid SMEDDS, optimized tablet batch was carried out in buffer (pH 7.4) at 37oC. The optimized formulation showed almost 100% drug release in 30 min and it was significantly higher than that of pure drug. Conclusion: The study indicated the significance of aceclofenac SMEDDS as prospective carrier with enhanced dissolution characteristics for oral administration.Keywords: Aceclofenac, solid-SMEDDS, neusilin, phase diagram, co-surfactant, cloud point, phase separation.
Current Nanomedicine
Title:Development and Evaluation of Solid Self-Microemulsifying Drug Delivery System of Aceclofenac Using Neusilin
Volume: 7 Issue: 2
Author(s): Kanav Midha, Manju Nagpal*, Garima Singh, Geeta Aggarwal and Thakur Gurjeet Singh
Affiliation:
- Chitkara College of Pharmacy, Chitkara University, Chandigarh- Patiala National Highway, Rajpura- 140401,India
Keywords: Aceclofenac, solid-SMEDDS, neusilin, phase diagram, co-surfactant, cloud point, phase separation.
Abstract: Objective: Self-microemulsifying drug delivery system (SMEDDS) of aceclofenac was developed to alleviate poor solubility and bioavailability issues.
Methods: The selection of components (oil, surfactant and co-surfactant) was based on saturated solubility studies and self emulsification ability. Pseudoternary phase diagrams were constructed to identify the self-emulsifying region. Isopropyl Myristate (IPM) was selected as oil phase; Cremophore as surfactant and Transcutol as co-surfactant (S/CoS mix) (in ratio of 1:1) respectively as optimized components for the SMEDDS formulation. The formulated liquid SMEDDS was evaluated for its self-emulsification time, phase separation, viscosity, cloud point and droplet size analysis. The liquid SMEDDS were converted to Solid SMEDDS by adsorption on solid carrier (Neusilin US2). Solid SMEDDS were further characterized for SEM, XRD, FTIR studies and evaluated for drug content, micrometric properties. Further Solid SMEDDS were compressed into tablet dosage form. Results: In vitro drug release of liquid and Solid SMEDDS, optimized tablet batch was carried out in buffer (pH 7.4) at 37oC. The optimized formulation showed almost 100% drug release in 30 min and it was significantly higher than that of pure drug. Conclusion: The study indicated the significance of aceclofenac SMEDDS as prospective carrier with enhanced dissolution characteristics for oral administration.Export Options
About this article
Cite this article as:
Midha Kanav, Nagpal Manju*, Singh Garima, Aggarwal Geeta and Singh Gurjeet Thakur, Development and Evaluation of Solid Self-Microemulsifying Drug Delivery System of Aceclofenac Using Neusilin, Current Nanomedicine 2017; 7 (2) . https://dx.doi.org/10.2174/2468187306666161004120702
DOI https://dx.doi.org/10.2174/2468187306666161004120702 |
Print ISSN 2468-1873 |
Publisher Name Bentham Science Publisher |
Online ISSN 2468-1881 |
Call for Papers in Thematic Issues
Nanomaterials for Drug Delivery System in Chronic and Infectious Disease Therapy
The exploration of nanomaterials for drug delivery systems represents a cutting-edge frontier in modern medical research. In our Thematic Issue, we delve into the extensive scope of utilizing nanotechnology to combat chronic and infectious diseases. This emerging field holds tremendous promise, offering innovative solutions to longstanding challenges in healthcare. At ...read more
Phytoconstituents as Anticancer Agents: Bottleneck and Breakthrough
Cancer is a terrifying disease that ranks among the most pressing health concerns facing humanity and necessitates a proactive approach to treatment. Humans are given medicinal plants by nature to aid in their quest for improved health. Since ancient times, people have used plants and their bioactive substances as medicines. ...read more
![](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Insight Into the Emerging Role of Striatal Neurotransmitters in the Pathophysiology of Parkinson’s Disease and Huntington’s Disease: A Review
Current Neuropharmacology Persistent Pulmonary Hypertension of the Newborn: Therapeutical Approach
Mini-Reviews in Medicinal Chemistry Drug Repurposing in the Development of Anticancer Agents
Current Medicinal Chemistry Lifestyle Factors and Endothelial Function
Current Vascular Pharmacology Uncontrolled Hypertension and Oncology: Clinical Tips
Current Vascular Pharmacology A Screening Method for Potential Anti-pancreatic Cancer Candidate Compounds Based on Hsp90-Cdc37 Interaction Model in vitro
Letters in Drug Design & Discovery The Use of TNF Family Ligands and Receptors and Agents which Modify their Interaction as Therapeutic Agents
Current Drug Targets Rationale for New Drugs Targeting the Tissue Microenvironment in Patients with HCC
Current Pharmaceutical Design Influence of Vitamin D Level on Inflammatory and Prognostic Markers in COVID-19 - A Retrospective Study
Recent Advances in Food, Nutrition & Agriculture Patent Selections:
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Editorial (Thematic Issue: Medicinal Chemistry of Hepatitis C Virus: Current and Future Perspective)
Current Topics in Medicinal Chemistry Biased Agonism at the Parathyroid Hormone Receptor: A Demonstration of Functional Selectivity in Bone Metabolism
Mini-Reviews in Medicinal Chemistry Modulation of Inducible Nitric Oxide Synthase Activation by Immuno-suppressive Drugs
Current Drug Metabolism Signal Peptides - Promising Ingredients in Cosmetics
Current Protein & Peptide Science Editorial on the Occasion of the 20th Anniversary of Endocrine Metabolic Immune Disorders-Drug Targets Journal with a Kaleidoscopic Vision of Selected Publications
Endocrine, Metabolic & Immune Disorders - Drug Targets Patent Selections:
Recent Patents on Anti-Cancer Drug Discovery Aryl/heteroaryl Substituted Celecoxib Derivatives as COX-2 Inhibitors: Synthesis, Anti-inflammatory Activity and Molecular Docking Studies
Medicinal Chemistry Curcumin: A Review of its’ Efficacy in the Management of Psoriasis
Drug Delivery Letters Differential Kat3 Coactivator Usage Regulates Brain Metabolism and Neuronal Differentiation
Current Molecular Pharmacology Preface
Current Drug Metabolism